Finally, some good news for women with IBD: a study of 1100 women taking both biologics and immunomodulators found that the treatments are safe to use during pregnancy.
“This is very exciting news for women since we know the use of medication during pregnancy garners great concern for both the patient and the physician,” said Uma Mahadevan, MD, member of the Crohn’s & Colitis Foundation of America’s Clinical Research Alliance and Associate Professor of Medicine, University of California, Center for Colitis and Crohn’s Disease, San Francisco. “We need to educate women and the physicians that care for them that the biggest risk during pregnancy is a disease flare, not the medication.”
I don’t know what makes me happier, the outcome or the fact that Dr. Mahadevan works with my doctor. I think both. More at CCFA.org/news.